The FDA just changed the rules on peptides effective April 15, 2026. BPC 157, GHK Cu, MOTS C, and TB 500 have been removed from the Category 2 restricted compounding list. Here is what FDA approval awaited this month . : r biotech_stocks 7 FDA Headlines You Missed in January 2026 HCPLive FDA May Reverse Ban on 14 PeptidesWhat It Means for Your Beauty Routine Allure RFK Jr.'s peptide push could unleash risky drugs STAT First Opinion